New patent expiration for Santarus Inc drug GLUMETZA

Annual Drug Patent Expirations for GLUMETZA Glumetza is a drug marketed by Santarus Inc and is included in one NDA. It is available from two suppliers. There are three patents…

The post New patent expiration for Santarus Inc drug GLUMETZA appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog